The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
Open accessAbstract
Recombinant adenoviruses are among the most promising tools for vaccine antigen delivery. Recently, the development of new vectors has focused on serotypes to which the human population is less exposed in order to circumvent pre-existing anti vector immunity. This study describes the derivation of a new vaccine vector based on a chimpanzee adenovirus, Y25, together with a comparative assessment of its potential to elicit transgene product specific immune responses in mice. The vector was constructed in a bacterial artificial chromosome to facilitate genetic manipulation of genomic clones. In order to conduct a fair head-to-head immunological comparison of multiple adenoviral vectors, we optimised a method for accurate determination of infectious titre, since this parameter exhibits profound natural variability and can confound immunogenicity studies when doses are based on viral particle estimation. Cellular immunogenicity of recombinant E1 E3-deleted vector ChAdY25 was comparable to that of other species E derived chimpanzee adenovirus vectors including ChAd63, the first simian adenovirus vector to enter clinical trials in humans. Furthermore, the prevalence of virus neutralizing antibodies (titre >1:200) against ChAdY25 in serum samples collected from two human populations in the UK and Gambia was particularly low compared to published data for other chimpanzee adenoviruses. These findings support the continued development of new chimpanzee adenovirus vectors, including ChAdY25, for clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
Buchbinder, S. P., Mehrotra, D. V., Duerr, A., Fitzgerald, D. W., Mogg, R., Li, D., Gilbert, P. B., Lama, J. R., Marmor, M., del Rio, C., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61591-3 · Cited by 1,713
Simple and highly efficient BAC recombineering using galK selection
Warming, S. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni035 · Cited by 1,212
The polypeptides of adenovirus
Maizel, J. V., White, D. O., & Scharff, M. D. (1968) · Virology · doi:10.1016/0042-6822(68)90121-9 · Cited by 884
Recombineering: a homologous recombination-based method of genetic engineering
Sharan, S. K., Thomason, L. C., Kuznetsov, S. G., & Court, D. L. (2009) · Nature Protocols · doi:10.1038/nprot.2008.227 · Cited by 785
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
McElrath, M. J., De Rosa, S. C., Moodie, Z., Dubey, S., Kierstead, L., Janes, H., Defawe, O. D., Carter, D. K., Hural, J., Akondy, R., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61592-5 · Cited by 713
Adenoviruses as vaccine vectors
Tatsis, N., & Ertl, H. C. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.013 · Cited by 669
Chartier, C., Degryse, E., Gantzer, M., Dieterle, A., Pavirani, A., & Mehtali, M. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4805-4810.1996 · Cited by 653
Romero, P., Maryanski, J. L., Corradin, G., Nussenzweig, R. S., Nussenzweig, V., & Zavala, F. (1989) · Nature · doi:10.1038/341323a0 · Cited by 505
Adenoviruses as Gene-Delivery Vehicles
Wilson, J. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341809 · Cited by 476
Viruses as vaccine vectors for infectious diseases and cancer
Draper, S. J., & Heeney, J. L. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2240 · Cited by 353
Colloca, S., Barnes, E., Folgori, A., Ammendola, V., Capone, S., Cirillo, A., Siani, L., Naddeo, M., Grazioli, F., Esposito, M. L., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002925 · Cited by 300
Self-citationReplication-Defective Vector Based on a Chimpanzee Adenovirus
Farina, S. F., Gao, G.-P., Xiang, Z. Q., Rux, J. J., Burnett, R. M., Alvira, M. R., Marsh, J., Ertl, H. C. J., & Wilson, J. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.23.11603-11613.2001 · Cited by 272
Louis, N., Evelegh, C., & Graham, F. L. (1997) · Virology · doi:10.1006/viro.1997.8597 · Cited by 224
Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins
Kanopka, A., Mühlemann, O., Petersen-Mahrt, S., Estmer, C., Öhrmalm, C., & Akusjärvi, G. (1998) · Nature · doi:10.1038/30277 · Cited by 223
A Simian Replication-Defective Adenoviral Recombinant Vaccine to HIV-1 Gag
Fitzgerald, J. C., Gao, G.-P., Reyes-Sandoval, A., Pavlakis, G. N., Xiang, Z. Q., Wlazlo, A. P., Giles-Davis, W., Wilson, J. M., & Ertl, H. C. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1416 · Cited by 216
Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector
O’Hara, G. A., Duncan, C. J. A., Ewer, K. J., Collins, K. A., Elias, S. C., Halstead, F. D., Goodman, A. L., Edwards, N. J., Reyes-Sandoval, A., Bird, P., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir850 · Cited by 214
Self-citationChimpanzee Adenovirus Antibodies in Humans, Sub-Saharan Africa
Xiang, Z., Li, Y., Cun, A., Yang, W., Ellenberg, S., Switzer, W. M., Kalish, M. L., & Ertl, H. C. J. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1210.060078 · Cited by 178
Reyes-Sandoval, A., Berthoud, T., Alder, N., Siani, L., Gilbert, S. C., Nicosia, A., Colloca, S., Cortese, R., & Hill, A. V. S. (2010) · Infection and Immunity · doi:10.1128/iai.00740-09 · Cited by 176
Self-citationDunachie, S. J., Walther, M., Epstein, J. E., Keating, S., Berthoud, T., Andrews, L., Andersen, R. F., Bejon, P., Goonetilleke, N., Poulton, I., et al. (2006) · Infection and Immunity · doi:10.1128/iai.00590-06 · Cited by 164
Self-citationAlcock, R., Cottingham, M. G., Rollier, C. S., Furze, J., De Costa, S. D., Hanlon, M., Spencer, A. J., Honeycutt, J. D., Wyllie, D. H., Gilbert, S. C., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000490 · Cited by 161
Self-citationRoy, S., Vandenberghe, L. H., Kryazhimskiy, S., Grant, R. L., Calcedo, R., Yuan, X., Keough, M. P., Sandhu, A., Wang, Q., Medina-Jaszek, C. A., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000503 · Cited by 158
Hodgson, S. H. C., Duncan, C. J. A., Elias, S. C., Collins, K. A., Ewer, K., Spencer, A. J., Williams, A. R., Halstead, F. D., Moretz, S. E., Miura, K., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.176 · Cited by 156
Self-citationAdenovirus-Based Vaccines: Comparison of Vectors from Three Species of Adenoviridae
Chen, H., Xiang, Z., Li, Y., Kurupati, R. K., Jia, B., Bian, A., Zhou, D., Hutnick, N. A., Yuan, S., Gray, C., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00450-10 · Cited by 148
McShane, H., Behboudi, S., Goonetilleke, N. P., Brookes, R. H., & Hill, A. V. S. (2002) · Infection and Immunity · doi:10.1128/iai.70.3.1623-1626.2002 · Cited by 123
Self-citationRe-Engineering Adenovirus Vector Systems to Enable High-Throughput Analyses of Gene Function
Stanton, R. J., McSharry, B. P., Armstrong, M., Tomašec, P., & Wilkinson, G. W. G. (2008) · BioTechniques · doi:10.2144/000112993 · Cited by 116
Pinto, A. R., Fitzgerald, J. C., Giles‐Davis, W., Gao, G. P., Wilson, J. M., & Ertl, H. C. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6774 · Cited by 113
Chimpanzee-origin adenovirus vectors as vaccine carriers
Tatsis, N., Tesema, L., Robinson, E., Giles‐Davis, W., McCoy, K., Gao, G., Wilson, J. M., & Ertl, H. C. J. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302675 · Cited by 95
Reyes‐Sandoval, A., Sridhar, S., Berthoud, T. K., Moore, A., Harty, J. T., Gilbert, S. C., Gao, G., Ertl, H. C. J., Wilson, J. M., & Hill, A. V. S. (2008) · European Journal of Immunology · doi:10.1002/eji.200737672 · Cited by 92
Self-citationHavenga, M. J. E., Vogels, R., Zuijdgeest, D., Radošević, K., Mueller, S., Sieuwerts, M., Weichold, F., Damen, I., Kaspers, J., Lemckert, A. A. C., et al. (2006) · Journal of General Virology · doi:10.1099/vir.0.81956-0 · Cited by 92
Roy, S., Gao, G., Lu, Y., Zhou, X., Lock, M. W., Calcedo, R., & Wilson, J. M. (2004) · Human Gene Therapy · doi:10.1089/10430340460745838 · Cited by 88
Dudareva, M., Andrews, L., Gilbert, S. C., Bejon, P., Marsh, K., Mwacharo, J. K., Kai, O. K., Nicosia, A., & Hill, A. V. S. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.080 · Cited by 87
Self-citationCapone, S., Reyes‐Sandoval, A., Naddeo, M., Siani, L., Ammendola, V., Rollier, C. S., Nicosia, A., Colloca, S., Cortese, R., Folgori, A., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.10.041 · Cited by 79
Self-citationNeutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys
Ersching, J., Hernández, M. I. M., Cezarotto, F. S., Ferreira, J. D. S., Martins, A. B., Switzer, W. M., Xiang, Z., Ertl, H. C. J., Zanetti, C. R., & Pinto, A. R. (2010) · Virology · doi:10.1016/j.virol.2010.07.043 · Cited by 79
Multicopy plasmid modification with phage λ Red recombineering
Thomason, L. C., Costantino, N., Shaw, D. V., & Court, D. L. (2007) · Plasmid · doi:10.1016/j.plasmid.2007.03.001 · Cited by 78
Draper, S. J., Biswas, S., Spencer, A. J., Remarque, E. J., Capone, S., Naddeo, M., Dicks, M. D. J., Faber, B. W., de Cassan, S. C., Folgori, A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001760 · Cited by 76
Self-citationSridhar, S., Reyes‐Sandoval, A., Draper, S. J., Moore, A., Gilbert, S. C., Gao, G., Wilson, J. M., & Hill, A. V. S. (2008) · Journal of Virology · doi:10.1128/jvi.02568-07 · Cited by 73
Self-citationAn efficient method of directly cloning chimpanzee adenovirus as a vaccine vector
Zhou, D., Zhou, X., Bian, A., Li, H., Chen, H., Small, J. C., Li, Y., Giles‐Davis, W., Xiang, Z., & Ertl, H. C. J. (2010) · Nature Protocols · doi:10.1038/nprot.2010.134 · Cited by 68
Accelerated Titering of Adenoviruses
Bewig, B., & Schmidt, W. E. (2000) · BioTechniques · doi:10.2144/00285bm08 · Cited by 67
Complete nucleotide sequences and genome organization of four chimpanzee adenoviruses
Roy, S., Gao, G., Clawson, D. S., Vandenberghe, L. H., Farina, S. F., & Wilson, J. M. (2004) · Virology · doi:10.1016/j.virol.2004.03.047 · Cited by 48
Creation of a panel of vectors based on ape adenovirus isolates
Roy, S., Medina‐Jaszek, A., Wilson, M. J., Sandhu, A. K., Calcedo, R., Lin, J., & Wilson, J. M. (2010) · The Journal of Gene Medicine · doi:10.1002/jgm.1530 · Cited by 43
Mannervik, M., Fan, S., Ström, A.-C., Helin, K., & Akusjärvi, G. (1999) · Virology · doi:10.1006/viro.1999.9663 · Cited by 42
Larsen, K. C., Spencer, A. J., Goodman, A. L., Gilchrist, A., Furze, J. M., Rollier, C. S., Kiss‐Toth, E., Gilbert, S. C., Bregu, M., Soilleux, E. J., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.025 · Cited by 25
Self-citationHillis, W. D., & Goodman, R. (1969) · The Journal of Immunology · doi:10.4049/jimmunol.103.5.1089 · Cited by 23
Lin, J., Somanathan, S., Roy, S., Calcedo, R., & Wilson, J. M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.06.053 · Cited by 21
An improved reverse genetics system for generation of bovine viral diarrhea virus as a BAC cDNA
Fan, Z., & Bird, R. C. (2008) · Journal of Virological Methods · doi:10.1016/j.jviromet.2008.01.011 · Cited by 20
Cited by
Folegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., Bellamy, D., Bibi, S., Bittaye, M., Clutterbuck, E. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31604-4 · Cited by 2,419
Self-citationRamasamy, M. N., Minassian, A. M., Ewer, K. J., Flaxman, A. L., Folegatti, P. M., Owens, D. R., Voysey, M., Aley, P. K., Angus, B., Babbage, G., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32466-1 · Cited by 1,324
Self-citationChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
van Doremalen, N., Lambe, T., Spencer, A., Belij-Rammerstorfer, S., Purushotham, J. N., Port, J. R., Avanzato, V. A., Bushmaker, T., Flaxman, A., Ulaszewska, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2608-y · Cited by 914
Self-citationAdenovirus Infections in Immunocompetent and Immunocompromised Patients
Lion, T. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00116-13 · Cited by 861
COVID-19 vaccine development and a potential nanomaterial path forward
Shin, M. D., Shukla, S., Chung, Y. H., Beiss, V., Chan, S. K., Ortega-Rivera, O. A., Wirth, D. M., Chen, A., Sack, M., Pokorski, J. K., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0737-y · Cited by 659
Metadata
- Authors
- Dicks, M. D. J., Spencer, A. J., Edwards, N. J., Wadell, G., Bojang, K., Gilbert, S. C., Hill, A. V. S., & Cottingham, M. G.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-07-13
- Volume
- 7
- Issue
- 7
- Pages
- e40385
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2140284275
- Cited by
- 384
- References
- 46
- FWCI
- 6.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.